Literature DB >> 32352859

Suggestions Regarding the GEICAM/2003-11_CIBOMA/2004-01 Trial: Future Treatment Options for Early Triple-Negative Breast Cancer.

Yuko Usui1, Hiroto Ishiki1, Akihiko Shimomura1, Eriko Satomi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32352859     DOI： 10.1200/JCO.19.03406

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Additional capecitabine use in early-stage triple negative breast cancer patients receiving standard chemotherapy: a new era? A meta-analysis of randomized controlled trials.

Authors:  Feng Ye; Lei Bian; Jiahuai Wen; Ping Yu; Na Li; Xiaoming Xie; Xi Wang
Journal:  BMC Cancer       Date:  2022-03-12       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.